baber/WOPTO huggingface dataset:
Patent AU-619047-B2 (AU)
Title: Enteric film and preparation thereof
Inventor: ITOH SHUNICHI
IPC: A61K9/56
Filed: 1989-09-26
Granted: 1992-01-16
Abstract: An enteric film is produced by spraying on a material a mixed solution of (a) hydroxypropylmethylcellulose phthalate exhibiting a viscosity of about 136 to 204 centistokes as 10 % methanol/dichloromethane (1 : 1 by weight) solution at 20 DEG C, (b) polyethylene glycol presenting solid state at ambient temperature and (c) shellac, wherein respective ratios of (b) and (c) to (a) are 0.1 to 20 weight percent and 5 to 40 weight percent; and then drying the solution. The enteric film excels in film strength and acid resistance, and can be employed in pharmaceutical preparations.
Patent AU-687002-B2 (AU)
Title: In vitro test for helicobacter pylori
Inventor: CRIPPS ALLAN
IPC: C07K1/14
Filed: 1993-04-29
Granted: 1998-02-19
Abstract: Contemporary infection by Helicobacter pylori in a human or other mammal can be detected by detecting H. pylori-specific IgG antibody in saliva, or other mucous secretion, with an antigen preparation from H. pylori. Diagnosis depends on detection of the antigen-antibody complex. For improved reliability, the antigen preparation comprises H. pylori-derived components of about 265 kDa and about 340 kDa and is substantially free of an H. pylori-derived component of about 440 kDa. The antigen preparation may be immobilised onto a solid support such as a nitrocellulose strip.
Patent AU-734306-B2 (AU)
Title: G protein-coupled receptor antagonists
Inventor: MACKAY CHARLES R
IPC: A61K39/395
Filed: 1997-09-24
Granted: 2001-06-07
Abstract: The present invention relates to methods of inhibiting a mammalian C-C chemokine receptor 3 protein (CCR3). The invention further relates to methods of treating an inflammatory disease or condition. Administration of a compound which inhibits or promotes CCR3 function to an individual in need of therapy provides a new approach to selective modulation of leukocyte function, which is useful in a variety of inflammatory and autoimmune diseases, or in the treatment of infections. As a major leukocyte chemokine receptor present in leukocytes such as eosinophils and lymphocytes, the receptor provides a key target for drug screening and design.
Patent AU-673182-B2 (AU)
Title: Inflatable object, especially an air mattress, with a part acting as a pump
Inventor: GRAF JOSEF
IPC: H01R13/627
Filed: 1993-07-06
Granted: 1996-10-31
Abstract: PCT No. PCT/EP93/01748 Sec. 371 Date Jan. 31, 1995 Sec. 102(e) Date Jan. 31, 1995 PCT Filed Jul. 6, 1993 PCT Pub. No. WO94/03089 PCT Pub. Date Feb. 17, 1994An inflatable object, especially an air mattress, with a part acting as a pump and a part inflatable thereby. In the pump part there is a device for spreading its walls making it unnecessary initially to provide air via the user's mouth or a bellows. A particulate propellant material, which may also take the form of waste, is used. A propellant material is a material which can be compressed and which on decompression, with the introduction of air, increases its volume. To prevent propellant material particles from penetrating into the valve between the pump and the inflatable parts, an air-permeable wall is fitted in front of the valve.
Patent AU-618442-B2 (AU)
Title: A laminated material with good gas barrier properties, and a method for the manufacture of the material
Inventor: LOFGREN LARS
IPC: D21H27/30
Filed: 1990-01-10
Granted: 1991-12-19
Abstract: A laminated material for the manufacture of packing containers with good gas barrier properties or parts for such containers. The material (1) comprises a barrier layer (8) consisting of a mixture of amorphous polyamide and ethylene-vinyl alcohol copolymer serving as a gas barrier.
Patent AU-637593-B2 (AU)
Title: Percutaneous stent and method for retrieval thereof
IPC: A61F2/02
Filed: 1990-01-10
Granted: 1993-06-03
Abstract: A method of combining first and second self-expanding stents to form a stent assembly for insertion into a body passageway by: forming first and second stents each from a continuous first length of wire formed into a closed zig-zag configuration having an endless series of straight sections joined at their ends by a plurality of bends, the second stent having bends at one end defining eyes open at the straight sections of the second stent, engaging the eyes at one end of the second stent about bends at one end of the first stent and closing the eyes.
Patent AU-640360-B2 (AU)
Title: Subsea electrical conductive insert coupling
IPC: E21B33/038
Filed: 1990-01-18
Granted: 1993-08-26
Abstract: PCT No. PCT/GB90/00082 Sec. 371 Date Sep. 13, 1991 Sec. 102(e) Date Sep. 13, 1991 PCT Filed Jan. 18, 1990 PCT Pub. No. WO90/08406 PCT Pub. Date Jul. 26, 1990.Apparatus for coupling a subsea module to an umbilical termination head from a subsea installation which comprises a receiver (14) mounted on the module, a receiver (15) mounted on the umbilical, and a conductive insert coupling (CIC) (13). The receivers (13, 14) each have electrical terminal sets (24, 25). The CIC (13) has a pair of spaced electrical terminal sets (22, 23) in which respective terminals in each set are electrically connected by concentric conductive tubes. The receivers (14, 15) are arranged to receive the CIC (13) so that when it is in position in the receivers (14, 15), each of the CIC terminal sets (22, 23) contacts one of the receiver terminal sets (24, 25) thereby forming an electrical connection between the two receiver terminal sets (24, 25).
Patent AU-641647-B2 (AU)
Title: A process and an apparatus for pasteurizing and precooking uncooked pizza bases
Inventor: VIET TOAI LE
IPC: A23L5/10
Filed: 1990-05-07
Granted: 1993-09-30
Abstract: A glass-ceramic plate is heated by microwaves in order to bring it to a temperature between 250 and 300 DEG C, it is removed from the microwave field and the pizza base is arranged on the said plate for approximately 2 to 3 minutes. The device comprises a conveyor belt (1) with a plurality of glass-ceramic plates (2), the said belt having a zone of passage in a microwave-field tunnel (4) and a zone of passage in the free air.
Patent AU-704752-B2 (AU)
Title: Tube finning machine and method and product
Inventor: PIERCE DAVID BLAND
IPC: B21D53/08
Filed: 1996-05-01
Granted: 1999-05-06
Abstract: PCT No. PCT/GB96/01038 Sec. 371 Date Oct. 31, 1997 Sec. 102(e) Date Oct. 31, 1997 PCT Filed May 1, 1996 PCT Pub. No. WO96/35093 PCT Pub. Date Nov. 7, 1996A heat exchange unit for a heat exchanger which includes a first tube with an outer surface and extended surface members located axially along the outer surface. Each member has a tube engagement surface and are axially Positioned. There is also taught a heat exchange fin block having a heat exchange unit with a second tube interconnected to the first tube by the extended surface members, wherein the extended surface members being tube fins at predetermined axial spacings. A tube finning machine is disclosed which includes a base with clamping means mounted thereon, carrier means movable relative to the base, and drive means for moving the carrier means. The clamping means clamps a portion of the first tube, and the carrier means transports at least one fin to an axially predetermined position adjacent the portion. Also disclosed is a method of finning a tube which includes supporting the tube to include a free end, positioning a carrier means at a start position, presenting a fin to the carrier means with pre-set angular orientation, locating the fin upon the carrier means while the carrier means is at the start position, moving the carrier means to drive the fin over the free end of the tube and thereafter a predetermined distance along the tube, returning the carrier means without the fin to the start position, and repeating the cycle by presenting another fin to the carrier means with the angular orientation but with the carrier means having a smaller predetermined distance.
Patent AU-591114-B2 (AU)
Title: Process for the synthesis of 2,2,2-trifluoroethanol
Inventor: CHEMINAL BERNARD
IPC: C07C31/40
Filed: 1986-04-22
Granted: 1989-11-30
Abstract: The process for synthesizing 2,2,2-trifluoroethanol by liquid phase catalytic hydrogenation of a compound of formula:    <IMAGE>  (I)  in which R is a hydrogen atom or a linear or branched alkyl radical containing from 1 to 8 carbon atoms and optionally partially fluorinated, comprising carrying out the hydrogenation in the presence of a nickel catalyst and in the presence of an aliphatic tertiary amine as a cocatalyst.
Patent AU-712312-B2 (AU)
Title: Breathing circuit apparatus for a nebulizer
Inventor: SALTER PETER W
IPC: A61M11/00
Filed: 1996-06-03
Granted: 1999-11-04
Abstract: A breathing circuit apparatus used with a nebulizer device that generates an aerosol is adapted for use by a user for inhaling the aerosol through the user's nose and/or mouth and thereafter exhaling exhalation gas through the breathing circuit apparatus. The breathing circuit apparatus includes a container, an inlet valve, an outlet valve and a user connection port. The container defines an interior chamber therein and is coupled to the nebulizer device. The inlet valve is connected to the container and includes an air inlet port for one-way air flow of ambient air into the interior chamber. The inlet valve moves between a closed condition to prevent the ambient air from entering into the interior chamber and an opened condition to permit the ambient air to enter into the interior chamber. The outlet valve is connected to the container and includes a gas exhalation port for one-way gas flow of the exhalation gas. The outlet valve moves between a closed state to prevent exhalation gas from exiting the interior chamber and an opened state to permit exhalation gas to exit from the interior chamber. The user connection port is in fluid communication with the interior chamber and the user's nose and/or mouth when the user inhales and exhales. As the user inhales the aerosol from the interior chamber, the inlet valve is opened and the outlet valve is closed. As the user exhales, the inlet valve is closed and the outlet valve is opened to allow the exhalation gas to exit the interior chamber and discharge into the exterior ambient air.
Patent AU-637127-B2 (AU)
Title: Digital data reader of digital data recording sheet
IPC: G06K7/14
Filed: 1990-07-31
Granted: 1993-05-20
Abstract: The digital data reader has a Y-axis inner line calculator for calculating a number of Y-axis inner lines whose start points on an X-axis base line are determined by correcting the deviations of tilting angles with respect to the Y-axis inner lines and to the X-axis base line in comparison with Y-axis outer lines in a display area and with a tilting angle of a Y-axis base line with respect to the X-axis base line. Several X-axis inner lines whose start points on the Y-axis base line are determined by correcting the deviations of tilting angles with respect to the X-axis inner lines and to the Y-axis base line are calculated in comparison with X-axis outer lines in the display area and with the tilting angle of the X-axis base line with respect to the Y-axis base line. A mark area origin is determined by calculating the points of intersection of the Y-axis inner lines and the X-axis inner lines. The mark area is calculated on the basis of the mark area origin determined by the mark area origin detecting means. The reader reads the data on digital recording sheet according to transformation of the display area due to contraction and expansion of the recording sheet.
Patent AU-675506-B2 (AU)
Title: Cloning of enterokinase and method of use
Inventor: LAVALLIE EDWARD R
IPC: A61K31/54
Filed: 1994-01-13
Granted: 1997-02-06
Abstract: Provided are nucleic acid sequence sequences encoding enterokinase activity, the expression products thereof, and methods for using same.
Patent AU-725621-B2 (AU)
Title: Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
Inventor: JOHNSON BRIAN FRANK
IPC: A61K31/50
Filed: 1998-05-04
Granted: 2000-10-19
Abstract: This invention relates to the use of aldose reductase inhibitors in the treatment, prevention or reversal of diabetic cardiomyopathy in a human subject.
Patent AU-723831-B2 (AU)
Title: Medical bag
Inventor: NICOLA THOMAS
IPC: B65D30/02
Filed: 1996-09-26
Granted: 2000-09-07
Abstract: A heat-sterilisable medicinal pouch (10) is claimed, which comprises a tubular connector (18) and at least one chamber (12) whose inner surface is made of a matrix-phase polymer system. Pref. the matrix polymer of the matrix polymer system is a polyethylene homopolymer, a polypropylene homopolymer or a random polypropylene copolymer. The phase polymer is a styrene-ethylene/butylene-styrene triblock polymer (SEBS), a SEBS with a styrene-ethylene/butylene-styrene diblock component (SEB), a styrene-ethylene/propylene-styrene triblock copolymer (SEPS), a styrene-butadiene-styrene-triblock polymer (SBS) and/or a styrene-isoprene-styrene triblock polymer (SIS) and/or an ethylene-alpha-olefin copolymer. The phase polymer makes up 1-40 (pref. 10-20) wt.% of the matrix phase polymer system. The walls of the pouch are pref. multilayered and co-extruded.
Patent AU-609707-B2 (AU)
Title: Lightweight high power electromagnetic transducer and armature therefor
Inventor: FISHER GENE ALLEN
IPC: H02K23/56
Filed: 1986-12-23
Granted: 1991-05-09
Abstract: An electromagnetic transducer is disclosed that is lightweight and has a high power to weight ratio, with the transducer being capable of operation as an efficient motor, alternator or generator, and being particularly useful, for example, in connection with self-propelled vehicle applications such as passenger cars. The electromagnetic transducer can utilize a shell construction, which enhances heat removal, and includes a magnetic-flux producing assembly, having a plurality of spaced magnetic elements, and an armature assembly formed by a winding arrangement of dispersed conductive elements which are separated by flux carrying elements which, to the extent that such flux carrying elements are electrically conductive, are dispersed in one, two, or three dimensions to thus be dispersed-phase flux carrying elements. The armature conductors and flux carrying elements are dispersed to avoid creating opposing induced currents, or eddy currents, depending on the effect produced on transducer operation. This dispersal enables operation of the transducer at high efficiency with high torque being maintained even during high speed relative motion between the magnetic flux producing assembly and the armature with the combination of high torque and high speed producing higher power per unit weight than can now known devices.
Patent AU-701914-B2 (AU)
Title: Cellulose fibres with improved elongation at break, and methods for producing same
Inventor: MERALDI JEAN-PAUL
IPC: D01F2/00
Filed: 1996-08-05
Granted: 1999-02-11
Abstract: Fiber made of cellulose formate and fiber made of cellulose regenerated from cellulose formate. These fibers exhibit high tenacity and modulus properties, combined with improved values of elongation at break and of energy at break. Their elongation at break, in particular, is greater than 6%.Methods for producing these fibers. The fiber made of cellulose formate is obtained by spinning a liquid crystal solution of cellulose formate according to the so-called dry-jet-wet spinning method, the coagulation stage and the neutral washing stage which follow both being carried out in acetone. The fiber made of cellulose formate in a highly concentrated aqueous sodium hydroxide solution. The spinning and regeneration methods can be employed in line and continuously.Reinforcing assemblies based on such fibers. Articles reinforced by such fibers or assemblies, these reinforced articles being in particular tires.
Patent AU-592848-B2 (AU)
Title: Modulation of animal cellular responses with compositions containing isoxanthopterin-8-(1'-beta-aldoglycosidyl) derivatives
Inventor: GOODMAN MICHAEL G
IPC: C12N5/07
Filed: 1986-12-12
Granted: 1990-01-25
Abstract: Animal cellular responses, and particularly immune-related responses, are modulated by contacting such cells with a unit dose of a composition containing an effective amount of an isoxanthopterin-8-aldoglycoside. An isoxanthopterin has a structure that conforms to formula (I), wherein R1 is a substituent and R2 is an aldoglycoside.
Patent AU-586072-B2 (AU)
Title: Method and apparatus for gripping, conveying and releasing printed products
Inventor: EBERLE JURG
IPC: B65H29/04
Filed: 1987-02-26
Granted: 1989-06-29
Abstract: For grasping, conveying and releasing printed products, particularly those occurring in a stream or scale flow by means of an endless link chain (90), a method is proposed, together with an apparatus having gripping and clamping members (10) for performing this method. For gripping and release purposes the individual gripping and clamping member (10) is so operated by means of control runner (70, 70') (75, 75') that a springy clamping arm (24) pressing under pretension against a bearing arm (16) is raised relative to the latter out of a closed position into an open position for grasping printed sheet (D) and then for conveying purposes is returned in snap-like manner into the closed position by the restoring force of clamping arm (24). The individual gripping and clamping member (10) operatively connected to articulation (92) of link chain (90) is constructed in one piece and has a substantially hairpin-like shape, which is bent four times.
Patent AU-687416-B2 (AU)
Title: A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes GP 130
Inventor: SAVINO ROCCO
IPC: G01N33/68
Filed: 1994-06-23
Granted: 1998-02-26
Abstract: It has been found that the ligands of the group of cytokins similar to Interleukin 6 (IL-6), that is Oncostatin M (OSM), Leukemia Inhibitory Factor (LIF), Ciliary Neurotrophic Factor (CNTF) and Interleukin 11 (IL-11), induce formation of a receptor complex of which the membrane molecule gp 130 is a part. It is thus possible to formulate the hypothesis that two different surfaces of the protein (in this class of hormones), known as site 1 and site 2, bind to two different molecules: site 1 to the specific receptor and site 2 to gp 130. The invention allows the identification of these sites and the isolation of variants having, with respect to the wild hormone, a greater affinity for the specific receptor (superagonists and superantagonists) or affinity for gp 130 reduced or abolished (antagonists and superantagonists). The figure shows the construct pHen DELTA  hIL-6 and the production of phasmidic particles that can be used to select agonists of Interleukin 6.
Patent AU-603801-B2 (AU)
Title: Method and apparatus for verifying identity
Inventor: COSTELLO BRENDAN DAVID
IPC: G07C9/00
Filed: 1987-05-07
Granted: 1990-11-29
Abstract: The present invention relates to a method for verifying the identity of a person or for relating the identity of a person to a document or other thing presented by that person, which method comprises: a). Observing topographically related permanent natural physical characteristics on a person to provide a machine readable identification of the identity, relative orientation and relative location of a plurality of the observed characteristics; and b). Comparing the observed characteristics with a machine readable record of the identification of the identity, relative orientation and relative location of the corresponding topographically related permanent natural physical characteristics purporting to belong to that person; c) Establishing the existence or otherwise of substantial identity between a plurality of the characteristics held in the record and those observed, the establishment of identity being based upon the identification, relative orientation and relative position of at least some of the characteristics; characterised in that the establishment of identity also includes: i) selecting a first set of at least three of the characteristics, which may be the same or different, from the record and a second set of at least three of the characteristics, which may be the same or different, from the observed characteristics; ii) counting the numbers of some other permanent natural physical feature lying between each of the characteristics with respect to each and every other member of that set for each of the first and second sets; and iii) comparing the counts for each and every characteristic in a set with the corresponding counts for the other set to substantiate identity between the two sets.
Patent AU-642480-B2 (AU)
Title: Differential output stage
Inventor: BOUZIDI JEAN-PIERRE
IPC: H03F3/30
Filed: 1991-03-22
Granted: 1993-10-21
Abstract: This differential output stage (1) for electronic equipment is built up in the form a quadripole including two channels (aA, bB) each connecting an input (a, b) to an output (A, B) and includes means of formulating a feedback voltage from each channel to the other, and means forming, for each channel, an output voltage from this channel equal to a linear combination, identical for each of the channels, of the input voltage of this channel and of the said feedback voltages. 
<IMAGE>
Patent AU-611082-B2 (AU)
Title: Passive electronic component
Inventor: FLUNKERT HORST
IPC: H05K3/34
Filed: 1987-06-04
Granted: 1991-06-06
Abstract: A passive electric component suitable for SMD-technique and having a cylindrical supporting member or a supporting member in the form of a rectangular parallelepiped and having electric connection elements at its ends which surround the supporting member in the form of a tube and do not cover the end faces of the supporting member.
Patent AU-696361-B2 (AU)
Title: Packaging material having at least one line of weakness and process and apparatus for producing it
Inventor: ZIELKE HELMUT
IPC: B65D75/58
Filed: 1996-12-24
Granted: 1998-09-10
Abstract: A packaging material (21) has at least one line of weakness (23) consisting of weak points (25, 27) arranged at a distance in succession. For an essentially silent destruction of the line of weakness (23), there are zones of of reduced strength being preferably designed to merge continuously into one another as weak points (25, 27). The packaging material preferably consists of cellophane or of biologically degradable plastic foil. The zones of reduced strength can also consist of webs of varying size between perforations of a line of weakness. The invention thereby achieves the destruction of a line of weakness which is staggered in time and which allows an essentially silent opening of packs produced from the packaging material, especially those for articles of hygiene, such as tampons for feminine hygiene. <IMAGE>
Patent AU-592005-B2 (AU)
Title: Process for separating a fluid feed mixture containing hydrocarbon oil and an organic solvent
Inventor: HAAN JOHANNES PIETER
IPC: B01D61/38
Filed: 1987-08-05
Granted: 1989-12-21
Abstract: Process for separating a fluid feed mixture containing hydrocarbon oil and an organic solvent (e.g. obtained from a furfural extraction unit) by contacting said fluid feed mixture at elevated pressure with one side of a hydrocarbon oil-selective membrane (e.g. containing a layer of a silicone polymer) which is substantially impermeable to said organic solvent and recovering hydrocarbon oil permeate from the other side of the membrane.
Patent AU-659086-B2 (AU)
Title: Radionuclide labelled particles useful for radiation synovectomy
Inventor: DEUTSCH EDWARD A
IPC: A61K51/00
Filed: 1991-04-11
Granted: 1995-05-11
Abstract: Novel radiation synovectomy compositions and their use for ablating the inflamed synovium of the synovial joint of an individual suffering from arthritis.